Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial - Concepedia

Concepedia

Publication | Closed Access

Characteristics of pyrexia in BRAFV600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial

88

Citations

21

References

2014

Year

Alexander M. Menzies, Michelle T. Ashworth, S. Swann, Richard Kefford, Keith T. Flaherty, Jeffrey S. Weber, Jeffrey R. Infante, K.B. Kim, René González, Omid Hamid,

Annals of Oncology

MedicineMelanomaPathologyCombined DabrafenibCancer TreatmentOncologyRadiation Oncology

References

	Year	Citations

Page 1